<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>ijcicr</PublisherName>
      <JournalTitle>International Journal of Clinical Investigation and Case Reports</JournalTitle>
      <PISSN>C</PISSN>
      <EISSN>l</EISSN>
      <Volume-Issue>Volume 1, Issue 3</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>Nov-Dec</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>2022</Year>
        <Month>11</Month>
        <Day>18</Day>
      </PubDate>
      <ArticleType>Oncology</ArticleType>
      <ArticleTitle>Mesonephric Remnants of the Diaphragm: A Major Pitfall in a Patient with Oesophageal Carcinoma</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>63</FirstPage>
      <LastPage>66</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Castiglione</FirstName>
          <LastName>R*</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Unganz</FirstName>
          <LastName>C</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Outrata</FirstName>
          <LastName>I</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Sued</FirstName>
          <LastName>S</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Sobotta</FirstName>
          <LastName>K</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Andus</FirstName>
          <LastName>T</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Köninger</FirstName>
          <LastName>J</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Dettmer MS</FirstName>
          <LastName>(GERMANY)</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI>10.55828/ijcicr-13-12</DOI>
      <Abstract>Mesonephric remnants represent a benign epithelial glandular proliferation derived from the lack of complete regression of the mesonephric ducts in embryogenesis. They are usually incidental findings and can cause confusion and diagnostic failures since they appear as glands outside the context of a glandular organ. Here we introduce the case of an 80-year-old man presented to the Chirurgical Department due to oesophageal stenosis in a context of a signet-ring cell carcinoma of the gastroesophageal junction. The CT-scan study demonstrated liquid retention in the esophagus and peritoneal carcinomatosis was suspected. Laparoscopy revealed multiple white spots on the peritoneal oesophageal hiatus which were biopsied. On microscopic examination, tubular formations with a monomorphic, cubic epithelial lining were seen which showed immunohistochemically a strong reactivity of CK-7 and Ber-EP4 and negativity for TTF-1, WT1, Calretinin, PAX-8, and CDX2 (Figure 2). A local metastasis of the oesophageal carcinoma was excluded based on morphology and immunohistochemistry and the diagnosis of mesonephric remnants was made. Here we present a rare but potentially grave pitfall and to our best knowledge the first case of mesonephric remnants within the diaphragm.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Mesonephric Remnants,Diaphragm,Immunohistochemistry,Adenocarcinoma,Glandular Formation</Keywords>
      <URLs>
        <Abstract>https://ijcicr.com/ubijournal-v1copy/journals/abstract.php?article_id=14192&amp;title=Mesonephric Remnants of the Diaphragm: A Major Pitfall in a Patient with Oesophageal Carcinoma</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Val-Bernal JF, Mayorga MM, Calapaquand;iacute;-Terand;aacute;n AK, Toledo E. Incidental mesonephric remnant hyperplasia of the jejunal mesentery: A diagnostic challenge. Pathol-Res and Pract. 2021;220:153388.&#13;
	Roy SF, Wong J, Latour M, Reichetzer B, Rahimi K. Ductal-type mesonephric duct/remnant hyperplasia: distinguished from lobular or diffuse mesonephric hyperplasia by the presence of a myoepithelial cell layer and micropapillary tufting. Pathology. 2022;54(3):378-381.&#13;
	Deolet E, Arora I, Van Dorpe J, Van der Meulen J, Desai S, Van Roy N, et al. Extrauterine Mesonephric-like Neoplasms: Expanding the Morphologic Spectrum. Am J Surg Pathol. 2022;46(1):124-133.&#13;
	Howitt BE, Nucci MR. Mesonephric proliferations of the female genital tract. Pathology. 2018;50(2):141-150.&#13;
	Perunovic B. Benign/nonneoplastic epithelial lesions Mesonephric rests/remnants. PathologyOutlines.com. 2022.&#13;
	Gikas PW, Del Buono EA, Epstein JI. Florid hyperplasia of mesonephric remnants involving prostate and periprostatic tissue. Possible confusion with adenocarcinoma. Am J Surg Pathol. 1993;17(5):454-460.&#13;
	Cagle PT, Churg A. Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies. Arch Pathol Lab Med. 2005;129(11):1421-1427.&#13;
	Kradin RL, Mark EJ. Distinguishing benign mesothelial hyperplasia from neoplasia: a practical approach. Semin Diagn Pathol. 2006;23(1):4-14.&#13;
	Ordonez NG. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. Am J Surg Pathol. 1998;22(10):1203-1214.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>